UBC was recognized in the 2023 CRO Leadership Awards by both small and big pharma as a winner in the Reliability category. This category recognizes companies that exceed customer expectations in meeting overall project timelines, operational excellence, and staff turnover. UBC was previously recognized for these awards for our work in Phase IV research in 2018 and 2019.
The CRO Leadership Awards are Clinical Leader and Life Science Leader’s industry awards backed by a quality benchmarking survey sent to pharmaceutical companies by ISR Reports. UBC is honored to be recognized by our customers from the past 18 months as an overall winner in the Reliability category.
At the awards ceremony during DIA’s Global Annual Meeting, Head of Evidence Development Aaron Berger sat down with Penelope Przekop from PDC Pharma Strategy to discuss the award, what it means for UBC, and what helps drive UBC’s reputation in the industry.
Congratulations to UBC’s Evidence Development team on this accomplishment! Learn more about UBC’s research services that operate at the intersection of access and evidence here.
